Please assess the completion status of the following clinical trial:

Trial Title: The Effect of NIV on QoL and Exercise Capacity in a COPD Exercise Rehabilitation Program

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosis of COPD III+IV~* Age \>18 years~* Former NIV treatment for at least 6 weeks with a positive end-expiratory pressure of at least 4 cmH2O and a pressure support of 8 cmH2O or higher~Exclusion Criteria:~* Pulmonary Exacerbation requiring antibiotic treatment or hospitalization during the last 6 weeks~* non-pulmonary Exercise impairment (amputation, severe heart disease, etc)~* any disease that precludes exercise training~* inability to understand the patient information~* substance abuse~* oxygen requirement of more than 6l O2/min during exercise

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 120 Years
- Healthy Volunteers: f

Study Arms:
- Control Arm (Type: NO_INTERVENTION): This arm will perform the pulmonary rehabilitation as specified with no respiratory assistance.
- Intervention Arm (Type: ACTIVE_COMPARATOR): This arm will conduct the pulmonary rehabilitation program with BiLevel Noninvasive Ventilation assistance from a ResMed ventilator.

Based on this trial design, predict the completion outcome and termination type (if applicable).